首页> 美国卫生研究院文献>World Journal of Gastroenterology >Intravenous administration of glutathione protects parenchymal and non-parenchymal liver cells against reperfusion injury following rat liver transplantation
【2h】

Intravenous administration of glutathione protects parenchymal and non-parenchymal liver cells against reperfusion injury following rat liver transplantation

机译:静脉内给予谷胱甘肽可保护实质和非实质肝细胞免受大鼠肝移植后的再灌注损伤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: To investigated the effects of intravenous administration of the antioxidant glutathione (GSH) on reperfusion injury following liver transplantation.METHODS: Livers of male Lewis rats were transplanted after 24 h of hypothermic preservation in University of Wisconsin solution in a syngeneic setting. During a 2-h reperfusion period either saline (controls, n = 8) or GSH (50 or 100 μmol/(h·kg), n = 5 each) was continuously administered via the jugular vein.RESULTS: Two hours after starting reperfusion plasma ALT increased to 1 457 ± 281 U/L (mean ± SE) in controls but to only 908 ± 187 U/L (P < 0.05) in animals treated with 100 μmol GSH/(h·kg). No protection was conveyed by 50 μmol GSH/(h·kg). Cytoprotection was confirmed by morphological findings on electron microscopy: GSH treatment prevented detachment of sinusoidal endothelial cells (SEC) as well as loss of microvilli and mitochondrial swelling of hepatocytes. Accordingly, postischemic bile flow increased 2-fold. Intravital fluorescence microscopy revealed a nearly complete restoration of sinusoidal blood flow and a significant reduction of leukocyte adherence to sinusoids and postsinusoidal venules. Following infusion of 50 μmol and 100 μmol GSH/(h·kg), plasma GSH increased to 65 ± 7 mol/L and 97 ± 18 mol/L, but to only 20 ± 3 mol/L in untreated recipients. Furthermore, plasma glutathione disulfide (GSSG) increased to 7.5 ± 1.0 mol/L in animals treated with 100 μmol/(h·kg) GSH but did not raise levels of untreated controls (1.8 ± 0.5 mol/L) following infusion of 50 μmol GSH/(h·kg) (2.2 ± 0.2 mol/L).CONCLUSION: Plasma GSH levels above a critical level may act as a “sink” for ROS produced in the hepatic vasculature during reperfusion of liver grafts. Therefore, GSH can be considered a candidate antioxidant for the prevention of reperfusion injury after liver transplantation, in particular since it has a low toxicity in humans.
机译:目的:研究静脉内给予抗氧化剂谷胱甘肽(GSH)对肝移植后再灌注损伤的作用。方法:雄性Lewis大鼠的肝脏经低温保存24小时后在威斯康星大学溶液中同种移植。在2小时的再灌注期间,通过颈静脉连续注入盐水(对照组,n = 8)或GSH(50或100μmol/(h·kg),n = 5)。结果:开始再灌注后两小时在对照组中,血浆ALT升高至1457±281 U / L(平均值±SE),而在用100μmolGSH /(h·kg)处理的动物中,血浆ALT仅升高至908±187 U / L(P <0.05)。 50μmolGSH /(h·kg)不能传递保护作用。在电子显微镜下的形态学发现证实了细胞保护作用:GSH处理可防止窦状内皮细胞(SEC)脱落以及微绒毛丧失和肝细胞线粒体肿胀。因此,缺血后胆汁流量增加了2倍。活体荧光显微镜检查显示正弦血流几乎完全恢复,并且白细胞对正弦和窦后小静脉的粘附显着降低。输注50μmol和100μmolGSH /(h·kg)后,血浆GSH分别增至65±7 mol / L和97±18 mol / L,但未经治疗的受试者仅增至20±3 mol / L。此外,在用100μmol/(h·kg)GSH处理的动物中,血浆谷胱甘肽二硫化物(GSSG)增加至7.5±1.0 mol / L,但在输注50μmol后未升高未处理对照组的水平(1.8±0.5 mol / L) GSH /(h·kg)(2.2±0.2 mol / L)。结论:血浆GSH水平高于临界水平可能是肝移植物再灌注过程中肝血管中产生的ROS的“汇”。因此,GSH被认为是预防肝移植后再灌注损伤的候选抗氧化剂,特别是因为它对人体的毒性低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号